Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
1992-11-25
|
pubmed:abstractText |
Lung cytochrome P-450 has been suggested to play a role in hypoxic pulmonary vasoconstriction. We reexamined this hypothesis using specific suicide substrate inhibitors of cytochrome P-450, 1-aminobenzotriazole (1-ABT), and chloramphenicol. In isolated, blood-perfused rat lungs, 1-ABT (0.5 mg/ml) and chloramphenicol (1 mg/ml) inhibited lung microsomal cytochrome P-450 (ethoxycoumarin O-deethylase) activity to 24 and 44% of control, respectively, and blunted hypoxia and angiotensin II-induced vasoconstriction. The depression of vascular contraction by 1-ABT was not due to an effect on calcium channels, since similar concentrations of 1-ABT had no inhibitory activity on electrical field-stimulated contractile response in rabbit papillary muscle strips. However, when 1-ABT was washed out of the lung after preincubation, the vascular reactivity to hypoxia and angiotensin II was restored despite persistent depression of lung cytochrome P-450 activity to 26% of control values. In isolated rat aortic and pulmonary arterial rings, addition of 1-ABT or metyrapone to the organ bath acutely reversed norepinephrine-induced contraction but preincubation with 1-ABT, metyrapone, or chloramphenicol had no effect on subsequent norepinephrine contractions. We conclude that 1-ABT inhibited lung vascular reactivity by a mechanism independent of cytochrome P-450 inhibition or calcium channel blockade and that an intact lung cytochrome P-450 system is not required for hypoxic pulmonary vasoconstriction in rat lungs.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-aminobenzotriazole,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Chloramphenicol,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System,
http://linkedlifedata.com/resource/pubmed/chemical/Metyrapone,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
263
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
L446-53
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1415722-Angiotensin II,
pubmed-meshheading:1415722-Animals,
pubmed-meshheading:1415722-Anoxia,
pubmed-meshheading:1415722-Aorta,
pubmed-meshheading:1415722-Chloramphenicol,
pubmed-meshheading:1415722-Cytochrome P-450 Enzyme System,
pubmed-meshheading:1415722-Electric Stimulation,
pubmed-meshheading:1415722-Lung,
pubmed-meshheading:1415722-Male,
pubmed-meshheading:1415722-Metyrapone,
pubmed-meshheading:1415722-Papillary Muscles,
pubmed-meshheading:1415722-Pulmonary Circulation,
pubmed-meshheading:1415722-Rabbits,
pubmed-meshheading:1415722-Rats,
pubmed-meshheading:1415722-Triazoles,
pubmed-meshheading:1415722-Vasoconstriction
|
pubmed:year |
1992
|
pubmed:articleTitle |
Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstriction.
|
pubmed:affiliation |
Cardiovascular Pulmonary Research Laboratory, Webb-Waring Lung Institute, University of Colorado Health Sciences Center, Denver 80262.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|